Randomized trial evaluates Gd2O3 nanoparticles' prooxidant effects in methylene blue photodegradation, suggesting therapeutic applications.
Paramagnetic gadolinium oxide (Gd 2 O 3 ) nanoparticles (NPs) with an average size of 24 ± 2 nm and pro-/antioxidant properties were obtained by hydrothermal synthesis. Energy-dispersive X-ray spectroscopy analysis confirmed the presence of substitutional dopant defects within the Gd 2 O 3 crystal lattice, specifically holmium (Ho 3+ , 0.15 at%) and europium (Eu 3+ , 0.05 at%). The Ho 3+ and Eu 3+ impurity defects confer luminescent and pro-oxidant properties to the Gd 2 O 3 NPs through an upconversion mechanism. Using spin-trapping electron paramagnetic resonance spectroscopy with 5,5-Dimethyl-1-pyrroline-N-oxide (DMPO) to detect hydroxyl radicals (•OH), the influence of Gd 2 O 3 NPs on the photo-oxidative degradation process of methylene blue under red light irradiation (λ ex = 660 ± 5 nm) was determined to be concentration-dependent and bidirectional. The combination of paramagnetic and pro-oxidant properties renders Gd 2 O 3 NPs highly promising for application in controlled combination theranostics, specifically as a contrast agent for magnetic resonance imaging and an efficient upconversion photosensitizer for photodynamic therapy.
No takes yet. Share an insight, caveat, or question.
Пугачевский et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: